WO2018025260A1 - Intracardiac devices comprising wire-supported valve leaflets - Google Patents

Intracardiac devices comprising wire-supported valve leaflets Download PDF

Info

Publication number
WO2018025260A1
WO2018025260A1 PCT/IL2017/050840 IL2017050840W WO2018025260A1 WO 2018025260 A1 WO2018025260 A1 WO 2018025260A1 IL 2017050840 W IL2017050840 W IL 2017050840W WO 2018025260 A1 WO2018025260 A1 WO 2018025260A1
Authority
WO
WIPO (PCT)
Prior art keywords
leaflets
device
intracardiac
leaflet
device according
Prior art date
Application number
PCT/IL2017/050840
Other languages
French (fr)
Inventor
Amit Tubishevitz
Shay Dubi
Yonatan GRAY
Original Assignee
Mvalve Technologies Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201662369115P priority Critical
Priority to US62/369,115 priority
Application filed by Mvalve Technologies Ltd. filed Critical Mvalve Technologies Ltd.
Publication of WO2018025260A1 publication Critical patent/WO2018025260A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents

Abstract

The present invention provides intracardiac devices suitable for implantation at a cardiac valve annulus, comprising a ring-shaped body, two or more movable leaflets, wherein each of said leaflets is attached to and supported by a metallic leaflet support frame. Each of said leaflets is capable of being moved between a closed conformation with its free edge in mutual edge-to-edge contact with the other leaflet(s) and an open, non-contact conformation. Preferably, the intracardiac devices of the present invention may be either prosthetic valve support devices or one-piece replacement valves.

Description

Intracardiac devices comprising wire-supported valve leaflets Field of the invention

The present invention relates to intracardiac devices. More specifically, the invention is concerned with replacement valves and replacement valve support devices that comprise valve leaflets attached to a support frame.

Background of the invention

Paravalvular leakage (PVL) is a well-known complication associated with the implantation of prosthetic intracardiac devices, such as replacement valves. Depending on the severity of the leakage, the consequences of PVL can range from the clinically insignificant to severe and even fatal outcomes, such as congestive heart failure and hemolysis. Thus, it has been observed by the present inventors that following the lateral displacement of the native mitral valve leaflets that occurs during the implantation of a replacement heart valve within a previously-deployed mitral valve support device (as disclosed, for example, in co-owned, co-pending international patent applications PCT/IL2013/000025, published as WO 2013/128436, and PCT/IL2013/000036, published as WO 2013/150512) leakage may occur between the lateral perimeter of said valve support device and the atrial wall.

It has also previously been found by the present inventors that intracardiac devices such as the aforementioned valve support devices may incorporate various elements for reducing PVL, including an inferiorly-directed circumferential fabric skirt attached to the inner circumference of the ring-shaped intracardiac device.

However, while the aforementioned fabric skirt has been found to reduce PVL to a certain degree, a need still exists for improved means for sealing the support device (or other intracardiac device) within the anatomical cardiac valve annulus.

In another co-owned patent application (PCT/IL2014/050476, published as WO2014/191994), the inventors described a cardiac valve support device fitted with valve leaflets, such that said device may itself function as a replacement valve - either over a very short time period, such as prior to the implantation of a prosthetic valve within the central space of said support device, or over a longer period of time of days, weeks or months. Clearly, it is essential to overcome, as much as is practically possible, the above-mentioned problem of leakage associated with intracardiac devices, in order to prevent the adverse clinical effects briefly discussed hereinabove. The present invention meets this need by providing an intracardiac device comprising improved sealing elements, wherein said elements may also function as highly effective replacement cardiac valve leaflets.

Summary of the invention

The present invention is thus primarily directed to an intracardiac device suitable for implantation at a cardiac valve annulus comprising a flattened annular or ring-shaped body having an outer and inner circumference, with an internal space bounded externally by said inner circumference, wherein said device further comprises two or more inferiorly-directed movable leaflets, each comprising a sheet of a biocompatible fabric or biological material (such as pericardium) attached by one of its edges to said ring-shaped body, wherein at least a portion of each of said leaflets is attached to and supported by a metallic leaflet support frame, wherein each of said leaflets has a free (i.e. non-attached) edge, such that each leaflet is capable of being moved between

(a) a closed conformation with its free edge in mutual edge-to-edge contact with the other leaflet(s), thereby substantially reducing or completely obliterating the internal space of the device, and

(b) an open conformation, wherein the free edges of each leaflet are not in mutual contact.

In one preferred embodiment of the present invention, the leaflet support frame is similar in size and outline shape to the leaflets which it is designed to support. In this embodiment, the frame is attached to the leaflets close to their outer border (e.g. by sewing with surgical suture material), such that the presence of said frame confers to the leaflets a greater degree of mechanical stability than they would possess in its absence. In other embodiments, the support provided by the leaflet support frame is only partial, in the sense that said frame does not support the entire leaflet perimeter, but rather only a portion thereof.

Preferably, said leaflets are attached at or close to the inner circumference of the ring- shaped body. It is to be noted that in some embodiments, each of the two or more leaflets are constructed from separate pieces of biocompatible fabric or biological tissue, while in other embodiments, they may all be formed from a single piece of said fabric or tissue.

As noted above, each of the movable leaflets is attached by one of its edges to said ring- shaped body. This attachment is generally implemented by means of sewing the leaflet (e.g. with surgical suture material) either to the fabric cover of the body of the device (only) or to both said fabric cover and the metallic device body itself.

Generally, when the intracardiac device (e.g. a prosthetic valve support device) is implanted within the mitral valve annulus, said device will have two movable leaflets. However, it is to be recognized that both when used in the mitral position and when implanted at other locations within the heart, the intracardiac device may be fitted with three or even more leaflets.

The orientation defined above as "inferiorly-directed" is to be understood as the direction facing downwards in a standing individual, after the device has been implanted within a cardiac valve annulus of said individual.

Preferably, the above-defined intracardiac device further comprises two or more stabilizing arms, the purpose of which is to apply forces onto the inner cardiac wall close to the annulus, in order to stabilize the device within the annulus and to prevent its displacement as a result of the hydrodynamic forces and muscular contraction forces generated at various stages during the cardiac cycle. In such embodiments, the device normally comprises two stabilizing arms attached to the ring-shaped device body, each of said arms being disposed around the device body such that they are approximately opposite each other. Suitable examples of elongate stabilizing arms that may be used to construct the intracardiac device of the present invention may be found in co-owned international patent application no. PCT/IL2014/000004 (published as WO2014/111918).

In one preferred embodiment, the aforementioned leaflets are attached only to the ring- shaped device body, and not to the stabilizing arms. In another preferred embodiment, the leaflets are attached both to the ring-shaped device body and to the stabilizing arms.

In one preferred embodiment, the intracardiac device of the present invention is a cardiac valve support device which is used to provide a stable "landing platform" for a prosthetic cardiac valve which is subsequently implanted within the central space of said support device, as described in co-owned, co-pending patent applications published as WO 2013/128436 and US 2014/0005778, the contents of both of which are incorporated herein in their entirety. However, it is to be recognized that the movable leaflets comprising a metallic leaflet support frame of the present invention are also intended for use in conjunction with other forms of cardiac support device not disclosed in those two publications.

In another preferred embodiment, the intracardiac device is a single-unit replacement valve, comprising both a valve-anchoring structure (i.e. the ring-shaped body) and valve leaflets, wherein the above-defined movable leaflets replace or supplement the function of the native cardiac valve leaflets.

In one preferred embodiment, the movable leaflets are constructed from one or more biocompatible fabrics. Non-limiting examples of such fabrics include PTFE, polyurethane, polyester, and/or PET (Dacron). In certain embodiments, the skirt may be constructed from a biological material such as pericardial tissue. In some embodiments, the leaflets may be constructed from two or more different fabrics and/or biological materials. In other preferred embodiments, the skirt may be constructed from materials (either a single material or a combination of materials) having at least two different thicknesses in different portions thereof.

Preferably, the leaflets are sutured to the device body with biocompatible surgical sutures, as is well known in the art. In one particularly preferred embodiment of the present invention, the above-defined intracardiac device is suitable in size and shape to be implanted at the mitral valve annulus.

Brief description of the drawings

Various embodiments of the present invention will be described hereinbelow with the aid of the following drawings:

Fig. 1 provides a side view of an embodiment of the present invention, in which the movable leaflets are shown in their closed conformation.

Fig. 2 provides an additional side view of the device shown in Fig. 1, viewed along the commissural line.

Fig. 3 shows further details of the arrangement of the movable leaflets in relation to the device body and stabilizing arms.

Fig. 4 depicts a device of the present invention similar to that shown in Fig. 1, in which it may be seen that the movable leaflets are sutured only to the device body, and not to the stabilizing arms.

Fig. 5 depicts exemplary cutting templates for preparing leaflets constructed of (a) pericardium, and (b) PET.

Fig. 6 depicts a Nitinol frame suitable for supporting the leaflets in a device of the present invention.

Fig. 7 compares, in plan view, the outline shape of the free edges of the movable leaflets of a device of the present invention (left side) with a prior art device that is not fitted with a metal frame, during diastole (upper pictures) and systole (lower pictures).

Fig. 8 presents a plan view of an alternative embodiment of the device of the present invention, in which the stabilizing anchors are oriented about 90 degrees to the prosthetic leaflet commissural line. Fig. 9 depicts, in side view, the metallic framework of an embodiment of a device, similar to that shown in Figs. 1-4, prior to it being attached to its fabric cover.

Detailed description of preferred embodiments

An example of a valve support device of the present invention, intended for implantation at the mitral position, is shown, in side view, in Fig. 1. It may be seen from this figure that the device 10 comprises a ring-shaped body 11 having an outer circumference 12o and an inner circumference 12i, to which are attached two movable leaflets 14 (shown in here in their closed conformation). The shape of the underlying Nitinol leaflet support frame 15 is also visible underneath the fabric component of the leaflet. The leaflets are attached to the inner circumference of the device body by means of sutures 16. The device also comprises two stabilizing arms 17, which are aligned along the commissural line formed by the apposition of the two leaflets in their closed position, as well as a lateral extension "crown" 18, which assists with both device stabilization and sealing. As seen in this figure, the entire device body (as well as the stabilizing arms and lateral extension structure) is covered with a biocompatible fabric.

The same device 20 is shown in Fig. 2, but viewed from a different aspect, namely along the commissural line between the two nearly-closed leaflets 22. It may be seen from this figure that said leaflets are orientated such that their line of closure runs approximately from one of the stabilizing arms 24 to the other. The reason for this arrangement is that valve support device 20 is intended for implantation at the mitral valve annulus such that the two stabilizing arms 24 are aligned between the two native mitral valve leaflets (i.e. along the anatomical commissure line), in order that they will not interfere with the function of said leaflets, prior to implantation of the final prosthetic valve. However, in some preferred embodiments, the orientation of the commissure line is arranged such that it is not exactly aligned with the imaginary line joining the two stabilizing arms. Rather, in such cases, as shown in Fig. 3, the arrangement of the stabilizing arms 32 in relation to the commissural line of the movable leaflets 34 is such that there is a noticeable offset angle between said commissure and an imaginary line joining the two stabilizing arms. In this type of embodiment, the reason for ensuring that there is a slight offset between these structures is that in certain cases, when the stabilizing arms are placed in line with the leaflet commissure, interference problems may arise during the crimping process in which the entire device is caused to adopt a collapsed conformation, in order to enable its insertion in a small diameter delivery device.

In a further embodiment, the relative spatial arrangement of the stabilizing arms and the prosthetic leaflet commissure line is entirely different from that described above. Thus, in this embodiment, as shown in Fig. 8, the stabilizing arms 82 are aligned at about 90 degrees to the commissural line of the device's leaflets 85 (which essentially is the imaginary line connecting the two junction points 87 between the leaflet support frames).

In certain circumstances, this arrangement may be particularly advantageous. One such advantage of this design is the improved hemodynamics of the valve component of the device, since the preloaded stabilizing arms are now essentially disconnected from valve commissures, and thus cannot cause any mutual mechanical interference. A further advantage of this embodiment relates to the fact that the anatomically-produced preload of the stabilizing arms actually results in an overall tightening of the valve structure, thus permitting improved leaflet coaptation.

It is to be recognized that although in the device shown in Fig. 8 the line joining the two stabilizing arms is disposed at about 90 degrees to the commissural line, this angular disposition may be different in other embodiments, all of which fall within the scope of the present invention.

As explained hereinabove, in some preferred embodiments, the movable leaflets are constructed from a biocompatible fabric (such as - but not limited to - PTFE, polyurethane, polyester, and/or PET (Dacron). In other embodiments, the leaflets are made entirely from a biological tissue layer (for example pericardium), or a combination of a biological tissue with a biocompatible fabric. Generally, the leaflets are attached to the device body using a biocompatible surgical suture, as is well known in the art. In this regard, it is to be noted, as shown in Fig. 4, that in most preferred embodiments of the present invention, the movable leaflets 42 are sutured only to the ring-like body 44 of the intracardiac device 40, and not to the stabilizing arms 46.

Fig. 9 presents a side view of an embodiment of an intracardiac device 90 of the present invention, similar to the embodiments shown in Figs. 1 to 4, prior to the device being attached to its fabric cover. It will be seen from this figure that the metallic leaflet support frame 92 is disposed on the inferior (i.e. ventricular) side of the ring-like body 94 of the device. In this embodiment, leaflet support frame 92 is constructed as a single unit, and comprises two sewing tab elements 95 which contain small apertures that are used for attaching said support frame to the leaflet fabric (or leaflet pericardium). It is to be noted that in this embodiment, the leaflet support frame 92 is not connected directly to device body 94 (or indeed to any other metallic element in the device). Rather the connection between said leaflet support frame and the other metallic elements of the device is achieved indirectly, via the fabric or pericardial leaflets. It is to be noted, however, that in other embodiments, the metallic leaflet support frame may be directly connected to the device body and/or stabilizing arms, for example by means of wire hinges or loops or by laser welding. This figure also depicts the uncovered stabilizing arms 96 and the lateral extension crown 98.

In some embodiments, the leaflets may be constructed from two or more different fabrics and/or biological materials. In other preferred embodiments, the leaflets may be constructed from materials (either a single material or a combination of materials) having at least two different thicknesses in different portions thereof.

As explained hereinabove, the two or more leaflets may be formed from separate pieces of a biocompatible fabric or biological material. In other embodiments, however, the leaflets may both (or all) be prepared from a single sheet of fabric or tissue and then become attached to the device body while still forming part of a single sheet. The first of these embodiments is illustrated in Fig. 5.

The lower part of this figure (B) depicts a cutting template that is used for leaflets that are constructed from biological tissue, such as pericardium, while the upper portion of the figure (A) shows a similar template that is used when the leaflets are prepared from a sheet of PET (Dacron). It is to be noted that the dimensions shown in this figure are in millimeters, and are provided for exemplary purposes only - leaflets of very different sizes and proportions may also be prepared for use in manufacturing the device of the present invention.

The present inventors have now unexpectedly found that the addition of a wire leaflet support frame to the leaflets results in significantly improved hemodynamic properties, which lead to both more complete prevention of PVL and more accurate leaflet opening and closure. Without wishing to be bound by theory, it is believed that this improvement is a consequence of the ability of the metallic frame to cause shaping of the leaflets into a form that possesses optimal hemodynamic flow parameters. Furthermore, the presence of the metallic frame provides a significant contribution to the structural integrity of the leaflets, thereby improving their ability to return to their working conformation ("de- crimping") upon the release of the intracardiac device from the confines of its delivery catheter or other delivery device.

The metallic leaflet support frame that is connected to the fabric or pericardial leaflets may be manufactured from any suitable biocompatible metal, including (but not limited to) Nitinol, Stainless steel, cobalt chromium and combinations thereof. In one preferred embodiment, the metallic frame is constructed from Nitinol. One particular advantage of the use of Nitinol is that it is a shape memory alloy which permits the framework to be cut out of sheet metal (or from stock wire) in flat form and then subjected to heat treatment using a mandrel having the desired three-dimensional shape, in order to create a leaflet frame having the desired curvature.

Fig. 6, in its upper portion (A), presents a flat pattern laser cut Nitinol leaflet support frame that is later subjected to heat treatment while secured to an appropriately shaped mandrel, in order to create the final desired shape frame with the required 3D curvature (B).

The design shown here is a bi-leaflet valve, but the same method could also be used to prepare a tricuspid valve leaflet, having similarly improved hemodynamic properties. As in the case of Fig. 5, the dimensions shown in this figure (in millimeters) are given by way of example only, and do not limit the scope of the invention in any way. While both the metal leaflet support frame and the fabric or tissue component of the leaflets may be constructed from materials of any suitable size (i.e. in accordance with the desired size of the finished device), exemplary sizes are as follows:

• Metallic wires, strips or plates having a thickness of 0.05-0.5mm.

• Biocompatible fabric strips or sheets (for example a PET fabric, such as manufactured by Secant Medical) having a thickness of 0.05-lmm.

• Biocompatible tissue (for example Bovine Pericardium) having a mean thickness of 0.05-0.5mm.

A typical process for manufacturing the movable leaflets of the present invention may be summarized as follows:

1. Nitinol laser cutting - a plate of Nitinol is cut with high precision using a template (as depicted in Fig. 6(A) to yield the outline shape shown in that figure.

2. Nitinol heat treatment -the cut flat shape obtained in step 1 is secured to an appropriate mandrel and subject to heat-treatment at 400 to 550 degrees C for 2-12 minutes in order to from a curved frame as shown in Fig. 6(B).

3. Nitinol Electro-polish - this process eliminates grads and sharps edges that might harm the fabric\biological tissue.

4a. Pericardium cutting - the Pericardium tissue is hand-cut according to Fig. 5(B).

4b. PET Laser cutting - the fabric is cut by laser to a shape as shown in Fig. 5(A).

5. The leaflets (either 5a or 5b) are connected to the wire leaflet support frame (i.e. the product of step3) by means of sewing with surgical sutures.

Generally, the ring-shaped body of the presently-disclosed intracardiac device is provided in the form of flat annular ring, preferably constructed from a material having superelastic and/or shape memory properties. One example of such a suitable material is Nitinol, which possesses both of the aforementioned physical properties. These properties may be utilized in order to permit said device, following its delivery in a collapsed conformation (within, for example, a delivery catheter or other dedicated delivery device), to return to an expanded memory configuration after being heated above its transition temperature.

In the radial plane (i.e. the plane in which the native cardiac valve leaflets are disposed when in their closed position), the size of the annular device body may be defined in terms of its outer radius (Ro), its inner radius (Ri) and the difference between these two radii (Rd). It should be appreciated that Ro is determined by the diameter of the valve annulus into which the valve support device will be implanted. In the case of valve support devices of the present invention, Ri, is determined by the outer diameter of the replacement heart valve that will be inserted into the central space of the support device. In the case of replacement of the native mitral valve, the prosthetic aortic valves used in conjunction with the valve support device of the present invention have an external diameter considerably less than that of the mitral valve annulus. It may therefore be appreciated that Rd approximately corresponds to the annular gap between the small outside-diameter replacement valve and the relatively large diameter mitral valve annulus. Preferably, Rd is in the range of 1 - 14 mm. In most embodiments of the valve support device of the present invention, the inner radius of the single-ring support element is in the range of 23-29 mm and the outer radius thereof is in the range of 30 - 50 mm.

With regard to the thickness of the support element (t) (as measured along the longitudinal axis of the element when in situ), t represents a compromise between the need for minimizing this parameter in order to facilitate crimping and insertion into a delivery catheter, and the need for the support device to be sufficiently rigid such that it is able to withstand the forces exerted by the beating heart without buckling. In one typical, non- limiting example, t is 0.4 mm, while Rd has a value of 5.5 mm. Indeed, as a general rule, in most embodiments of the annular support element of the present invention, Rd is significantly larger than t. For example, in many cases Rd may be between 2.5 and 35 times larger than t, more preferably between 10 and 20 times larger than t. It may be appreciated from the foregoing explanation that the ratio between Rd and t has functional significance for the valve support device of the present invention.

As indicated hereinabove, in a preferred embodiment of the invention, the valve support device is used to assist in the implantation of a prosthetic aortic valve into the mitral valve annulus of a human subject in need of such implantation. The thickness of the support device is generally in the range of 0.25 - 0.6 mm, more preferably 0.4 mm.

The intracardiac device may have an outline shape that is circular, elliptical or any other form that permits it to be adapted to make close contact with the inner cardiac wall upon implantation in the region of a cardiac valve annulus.

One particular feature of the valve support device of the present invention is the fact that the outer perimeter of the annular support structure is entirely rigid, such that in its deployed configuration, it is not possible to cause further expansion of the outer diameter of said device. However, the disk-like device body may comprise some cut-out areas (as described in co-owned US2015/0094802, which is incorporated herein in its entirety), such that the inner perimeter of said device body is elastically deformable in a radial-direction.

Some of the advantageous features of the frame-supported leaflets of the device of the present invention, when compared with similar devices having unsupported leaflets are shown in the following Example. This example is brought for the purpose of illustration only, and is not intended to limit the scope of the invention in any way.

Example

Comparative study: valve leaflet opening and closure

In order to investigate the hemodynamic properties afforded to the device by the incorporation of a metallic leaf support frame into the movable leaflets, a two-leaflet device of the present invention (as disclosed herein) was compared with a similar device comprising two unsupported leaflets (i.e. without a metallic frame), with respect to the ability of the leaflets to accurately open and close during various phases of the cardiac cycle.

Method:

The valve support devices (with and without Nitinol leaflet support frames) were deployed in a pulse duplicator (Heart valve pulse duplicator test system, BDC Laboratories, Colorado, USA) which produces pulsatile flow simulating in vivo pressures and flow rates during different phases of the cardiac cycle.

Results:

It may be seen from the upper panels of Fig. 7 that the leaflets of the device of the present invention fitted with a Nitinol leaflet support frame (a) are fully opened during the diastolic phase, while the unsupported leaflets of the control device (b) were unable to fully open during diastole. Similarly, during systolic contraction (lower panel on each side), it is clear that the leaflets of the device of the present invention (a) were able to completely close at their commissural line, while the unsupported leaflets of the control device (b) were still largely in their open conformation during systole.

The implication of these results is clear: the presence of the metallic leaflet frame support in the leaflets of the presently-disclosed device has resulted in a very marked improvement in the hemodynamic function of said leaflets as a valve structure, thereby enabling said leaflets to present a much larger effective orifice area when said valve is open, and a much lower regurgitation volume when closed.

In conclusion, the device of the present invention, in which the movable leaflets are supported by a metallic frame, is characterized by significantly improved valve function, as well as providing greatly improved sealing properties of the device when implanted within the mitral valve annulus.

Claims

1. An intracardiac device suitable for implantation at a cardiac valve annulus, comprising a ring-shaped body,
wherein said device further comprises two or more inferiorly-directed movable leaflets, each comprising a sheet of a biocompatible fabric or biological material attached by one of its edges to said ring-shaped body,
wherein each of said leaflets is attached to and supported by a metallic leaflet support frame,
and wherein each of said leaflets has a free edge, such that each leaflet is capable of being moved between a closed conformation with its free edge in mutual edge-to-edge contact with the other leaflet(s) and an open conformation, wherein the free edges of each leaflet are not in mutual contact.
2. The intracardiac device according to claim 1, wherein said device comprises two movable leaflets.
3. The intracardiac device according to claim 1, wherein said device comprises three movable leaflets.
4. The intracardiac device according to claim 1, wherein the movable leaflets comprise one or more biocompatible fabrics selected from the group consisting of: PTFE, polyurethane, polyester, and/or PET.
5. The intracardiac device according to claim 1, wherein the movable leaflets comprise pericardial tissue.
6. The intracardiac device according to claim 1, wherein the leaflet support frame attached to the leaflets comprises Nitinol.
7. The intracardiac device according to claim 1, wherein said device further comprises two or more stabilizing arms attached to the device body.
8. The intracardiac device according to claim 1, wherein said device is a valve support device.
9. The intracardiac device according to claim 1, wherein said device is a replacement cardiac valve.
10. The intracardiac device according to claim 1, wherein said device is suitable in size and form to be implanted at the mitral valve annulus.
PCT/IL2017/050840 2016-07-31 2017-07-27 Intracardiac devices comprising wire-supported valve leaflets WO2018025260A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201662369115P true 2016-07-31 2016-07-31
US62/369,115 2016-07-31

Publications (1)

Publication Number Publication Date
WO2018025260A1 true WO2018025260A1 (en) 2018-02-08

Family

ID=59714082

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2017/050840 WO2018025260A1 (en) 2016-07-31 2017-07-27 Intracardiac devices comprising wire-supported valve leaflets

Country Status (1)

Country Link
WO (1) WO2018025260A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10154903B2 (en) 2016-08-01 2018-12-18 Cardiovalve Ltd. Minimally-invasive delivery systems
US10226341B2 (en) 2011-08-05 2019-03-12 Cardiovalve Ltd. Implant for heart valve
US10357360B2 (en) 2015-02-05 2019-07-23 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10376361B2 (en) 2011-08-05 2019-08-13 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US10390952B2 (en) 2015-02-05 2019-08-27 Cardiovalve Ltd. Prosthetic valve with flexible tissue anchor portions
US10492908B2 (en) 2014-07-30 2019-12-03 Cardiovalve Ltd. Anchoring of a prosthetic valve
US10512456B2 (en) 2010-07-21 2019-12-24 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US10524903B2 (en) 2019-07-10 2020-01-07 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013128436A1 (en) 2012-02-28 2013-09-06 Mvalve Technologies Ltd. Single-ring cardiac valve support
WO2013150512A1 (en) 2012-04-05 2013-10-10 Mvalve Technologies Ltd. Cardiac valve support structure
US20140005778A1 (en) 2010-09-01 2014-01-02 Mvalve Technologies Ltd. Cardiac valve support structure
WO2014111918A1 (en) 2013-01-16 2014-07-24 Mvalve Technologies Ltd. Anchoring elements for intracardiac devices
WO2014191994A1 (en) 2013-05-29 2014-12-04 Mvalve Technologies Ltd. Cardiac valve support device fitted with valve leaflets
US20140379076A1 (en) * 2013-06-25 2014-12-25 Tendyne Holdings, Inc. Halo Wire Fluid Seal Device for Prosthetic Mitral Valves
US20150005874A1 (en) * 2013-06-27 2015-01-01 Tendyne Holdings, Inc. Atrial Thrombogenic Sealing Pockets for Prosthetic Mitral Valves
US20150094802A1 (en) 2012-02-28 2015-04-02 Mvalve Technologies Ltd. Single-ring cardiac valve support

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005778A1 (en) 2010-09-01 2014-01-02 Mvalve Technologies Ltd. Cardiac valve support structure
WO2013128436A1 (en) 2012-02-28 2013-09-06 Mvalve Technologies Ltd. Single-ring cardiac valve support
US20150094802A1 (en) 2012-02-28 2015-04-02 Mvalve Technologies Ltd. Single-ring cardiac valve support
WO2013150512A1 (en) 2012-04-05 2013-10-10 Mvalve Technologies Ltd. Cardiac valve support structure
WO2014111918A1 (en) 2013-01-16 2014-07-24 Mvalve Technologies Ltd. Anchoring elements for intracardiac devices
WO2014191994A1 (en) 2013-05-29 2014-12-04 Mvalve Technologies Ltd. Cardiac valve support device fitted with valve leaflets
US20140379076A1 (en) * 2013-06-25 2014-12-25 Tendyne Holdings, Inc. Halo Wire Fluid Seal Device for Prosthetic Mitral Valves
US20150005874A1 (en) * 2013-06-27 2015-01-01 Tendyne Holdings, Inc. Atrial Thrombogenic Sealing Pockets for Prosthetic Mitral Valves

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10512456B2 (en) 2010-07-21 2019-12-24 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US10226341B2 (en) 2011-08-05 2019-03-12 Cardiovalve Ltd. Implant for heart valve
US10376361B2 (en) 2011-08-05 2019-08-13 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US10492908B2 (en) 2014-07-30 2019-12-03 Cardiovalve Ltd. Anchoring of a prosthetic valve
US10357360B2 (en) 2015-02-05 2019-07-23 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10426610B2 (en) 2015-02-05 2019-10-01 Cardiovalve Ltd. Prosthetic valve with radially-deflectable tissue anchors
US10449047B2 (en) 2015-02-05 2019-10-22 Cardiovalve Ltd. Prosthetic heart valve with compressible frames
US10463487B2 (en) 2015-02-05 2019-11-05 Cardiovalve Ltd. Prosthetic valve delivery system with independently-movable capsule portions
US10463488B2 (en) 2015-02-05 2019-11-05 Cardiovalve Ltd. Prosthetic valve with separably-deployable valve body and tissue anchors
US10390952B2 (en) 2015-02-05 2019-08-27 Cardiovalve Ltd. Prosthetic valve with flexible tissue anchor portions
US10507105B2 (en) 2015-02-05 2019-12-17 Cardiovalve Ltd. Prosthetic valve with tissue anchors free from lateral interconnections
US10524910B2 (en) 2015-07-30 2020-01-07 Mitraltech Ltd. 3 Ariel Sharon Avenue Articulatable prosthetic valve
US10154903B2 (en) 2016-08-01 2018-12-18 Cardiovalve Ltd. Minimally-invasive delivery systems
US10426614B2 (en) 2016-08-01 2019-10-01 Cardiovalve Ltd. Minimally-invasive delivery systems
US10531866B2 (en) 2017-02-15 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10531872B2 (en) 2018-07-20 2020-01-14 Cardiovalve Ltd. Valve prosthesis configured for deployment in annular spacer
US10524903B2 (en) 2019-07-10 2020-01-07 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames

Similar Documents

Publication Publication Date Title
US9308087B2 (en) Sequentially deployed transcatheter mitral valve prosthesis
EP1977719B1 (en) Method of forming an implantable prosthetic valve
ES2550929T3 (en) Prosthetic heart valve that includes a stent structure and tissue leaflets and related procedures
US8591570B2 (en) Prosthetic heart valve for replacing previously implanted heart valve
AU2014231689B2 (en) Prosthetic valve with anti-pivoting mechanism
AU2017239620B2 (en) Methods and apparatus for engaging a valve prosthesis with tissue
US9597181B2 (en) Thrombus management and structural compliance features for prosthetic heart valves
US10433956B2 (en) Mitral prosthesis and methods for implantation
US9895221B2 (en) Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US9522062B2 (en) Mitral prosthesis and methods for implantation
JP6449369B2 (en) Device including an artificial valve
JP6576912B2 (en) Structural member for prosthetic mitral valve
US7955376B2 (en) Implantable medical device with constrained expansion
US9867698B2 (en) Valve prosthesis and method for delivery
US9439759B2 (en) Endoprosthesis for implantation in the heart of a patient
EP2155115B1 (en) Medical device for treating a heart valve insufficiency or stenosis
US8408214B2 (en) Method for implanting prosthetic valve
US10383728B2 (en) Methods and apparatus for delivering a prosthetic valve to a beating heart
US9877828B2 (en) Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8926694B2 (en) Dual valve prosthesis for transcatheter valve implantation
JP5687070B2 (en) Stent for prosthetic heart valve
AU2010256630B2 (en) Stented prosthetic heart valves
US8845720B2 (en) Prosthetic heart valve frame with flexible commissures
US8398704B2 (en) Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
JP5995110B2 (en) Intraventricular low profile prosthetic mitral valve

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17758300

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17758300

Country of ref document: EP

Kind code of ref document: A1